EOLS today
$6.96-$0.22 (-3.06%)close Nov 13, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourAscending Triangle
15 minSymmetric Triangle
5 minStrong Bullish
Daily trend turns up above $7.83
Key levels
Resistance$7.83
Resistance$7.15
Support$6.43
Support$5.72
Latest news & SEC filings
EarningsEvolus Releases Third-Quarter 2026 Earnings
AnalystBTIG lifts its Evolus target to $15
AnalystBTIG keeps Buy rating on Evolus, lifts price target to $15
All EOLS news →About Evolus
Evolus is a beauty-focused drugmaker that sells treatments people pay for themselves rather than through insurance. Its main offering is a botulinum toxin injection used to soften frown lines, sold under the Jeuveau name. It also markets a family of hyaluronic acid gels, branded Evolysse, that fill facial creases. Licensed skin care professionals are the buyers, and the products reach customers in North America, Europe, and Australia.
Based on the company's 10-K filed Mar 3, 2026.
Nasdaq · Healthcare
Evolus, Inc. (EOLS)
What Is the Price Target for EOLS?
SEPT Low Target
$13.00
SEPT Mid Target
$13.00
SEPT High Target
$13.00
Analyst Consensus
$13.00
Is EOLS a Buy or Sell Right Now?
Thesis
- •Revenue growing 11.6% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for EOLS.
Start Free Trial →Is EOLS Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$13.00
48
Moat Score
NARROW
2/9
Piotroski Score
-1.8
Altman Z-Score
What Is Smart Money Doing with EOLS?
Insider Signal
SELLING
0 buys / 5 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| MOATAZEDI DAVID | director officer | Sale | 105,108 | $950K | Sep 2, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →EOLS Growth Story
Revenue YoY
11.6%
3yr Revenue CAGR
26.0%
EPS Growth YoY
1.23%
FCF Growth YoY
-134.7%
Revenue Trend
STRONG
Dark Pool Trades for EOLS
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for EOLS, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 19:32:49 | $7.04 | 3,000 | $$21K | SELL |
| 19:23:28 | $7.09 | 8,063 | $$57K | SELL |
| 19:10:32 | $7.09 | 9,552 | $$68K | BUY |
| 19:05:02 | $7.05 | 6,473 | $$46K | BUY |
| 19:02:17 | $7.03 | 1,000 | $$7K | BUY |
5 dark pool trades shown · $$199K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Evolus, Inc. (EOLS) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →EOLS — frequently asked questions
What is EOLS stock price today?
Evolus, Inc. (EOLS) is at $6.96, down 3.06% (-$0.22) at the Nov 13, 2026 close.
Why is EOLS stock moving today?
Latest EOLS news — Nov 5, 2026: Evolus Releases Third-Quarter 2026 Earnings · Nov 5, 2026: BTIG lifts its Evolus target to $15
What is the EOLS price target?
The average analyst price target for EOLS is $13.00, ranging from $13 to $13, based on 1 analysts.
What do analysts rate EOLS?
Analyst ratings for EOLS: 0 Buy, 2 Hold, 0 Sell — consensus Hold.
Does EOLS pay a dividend?
EOLS does not currently pay a dividend.
How much debt does EOLS have?
Evolus, Inc. reported $157M of debt and $45M of cash (Jun 30, 2026).
What are EOLS support and resistance levels?
Support: $6.43, $5.72, $5.12. Resistance: $7.15, $7.83, $8.51.
What are insiders doing with EOLS?
Insider activity: SELLING, 0 buys and 5 sells in the last 90 days.
What is the latest news on EOLS?
Nov 5, 2026: Evolus Releases Third-Quarter 2026 Earnings · Nov 5, 2026: BTIG lifts its Evolus target to $15 · Nov 5, 2026: BTIG keeps Buy rating on Evolus, lifts price target to $15